FDA Launching New 24/7 Drug Entry Review Pilot
Published Mar 7, 2022
Summary
FDA's OEIO announced a 90-day pilot (March 13 to June 13, 2022) to review drug entries nationally with 24/7 staffing across all ports, aiming to improve efficiency and explore receiving documentation earlier in the entry process.
Summary is machine-generated at the linking layer for discovery only. Refer to the source bulletin for authoritative guidance.
CSMS 51230259 · full bulletinRelated bulletins
Consumer Product Safety Commission (CPSC) Implementation Guide and Partner Government Agency (PGA) Flag Enforcement Table Documents Updated on CBP.gov
Jul 28, 2026
Harmonized System Update (HSU) 2617
Jul 27, 2026
Harmonized System Update (HSU) 2616
Jul 23, 2026
Notice from the U.S. Fish and Wildlife Service regarding Final Rule Amending 50 CFR Part 10 Shellfish Definition and Updated Tariff Flagging
Jul 15, 2026
Harmonized System Update (HSU) 2615
Jul 14, 2026